Todd Foley, Director of Aktis Oncology AKTS, has filed 1 purchase and 4 sales on the open market. Over the past 12 months that comes to a net purchase of $4.2M. The latest trade was on 01/12.

TF

TF

Todd Foley

Director

Company

Aktis Oncology AKTS

First filing

23/06/05

Trades

16 trades

Buys / sales

1 / 4

12-month net buying

$4.2M

Last trade

01/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Aktis OncologyAKTS	Open-market buy	01/12	01/14	232,870 sh	$18.00	$4,191,660	+5.8%
IT iTeos Therapeutics	Open-market sale	25/05/13	25/05/15	630,191 sh	$8.06	$5,079,339.46	−23.0%
Werewolf TherapeuticsHOWL	Open-market sale	25/03/27	25/04/30	1,963 sh	$1.05	$2,061.15	−0.1%
Entrada TherapeuticsTRDA	Open-market sale	24/12/10–24/12/11	24/12/12	44,722 sh2 trades	$20.51avg.	$917,110.96	−1.0%